Loading live market data…

Viridian Therapeutics, Inc.

NASDAQ:VRDN

$19.06 USD

-$0.02 (-0.1%)

Volume
1.57M
Average Volume
2.52M
Market Capitalization
$1.72B
P/E Ratio
-5.48
Dividend Yield
0.00%
Price Target
$38.50
Year High
$34.29
Year Low
$13.18
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$15.15

VRDN Estimated and Actual Revenue by Quarter

VRDN Estimated and Actual EPS by Quarter

VRDN Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2028-12-31 6 -309.28M -177.91M -237.11M -309.28M -177.91M -237.11M
2028-09-30 3 -260.89M -150.07M -200.01M -260.89M -150.07M -200.01M
2028-06-30 5 -216.22M -124.38M -165.77M -216.22M -124.38M -165.77M
2028-03-31 3 -162.43M -93.44M -124.53M -162.43M -93.44M -124.53M
2027-12-31 7 -191.18M -109.97M -146.57M -191.18M -109.97M -146.57M
2027-09-30 4 -124.62M -71.69M -95.54M -124.62M -71.69M -95.54M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2028-12-31 6 30.65M 63.34M 45.38M 19.03B 33.08B 25.36B
2028-09-30 3 16.38M 33.85M 24.25M 16.05B 27.9B 21.39B
2028-06-30 5 3.31M 6.85M 4.91M 13.3B 23.12B 17.73B
2028-03-31 3 -28.59M -13.83M -20.48M 9.99B 17.37B 13.32B
2027-12-31 7 -16.9M -8.18M -12.11M 11.76B 20.45B 15.67B
2027-09-30 4 -62.16M -30.08M -44.54M 7.67B 13.33B 10.22B
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2028-12-31 6 177.91M 309.28M 237.11M 7 0.29988 0.61967 0.444
2028-09-30 3 150.07M 260.89M 200.01M 4 0.16027 0.33119 0.2373
2028-06-30 5 124.38M 216.22M 165.77M 6 0.03241938 0.0669913 0.048
2028-03-31 3 93.44M 162.43M 124.53M 4 -0.27969 -0.13535 -0.2004
2027-12-31 7 109.97M 191.18M 146.57M 6 -0.16534 -0.08001508 -0.11847
2027-09-30 4 71.69M 124.62M 95.54M 3 -0.60818 -0.29432 -0.43577